, Tracking Stock Market Picks
Enter Symbol:
Boston Scientific Corporation (BSX) [hlAlert]

Market Perform
down 17.76 %

Boston Scientific Corporation (BSX) downgraded to Market Perform with price target $5.50 by Northland Securities

Posted on: Friday,  Jul 27, 2012  8:25 AM ET by Northland Securities

Northland Securities rated Market Perform Boston Scientific Corporation (NYSE: BSX) on 07/27/2012. Previously Northland Securities rated Outperform Boston Scientific Corporation (NYSE: BSX)
on 03/02/2012., when the stock price was $6.08. Since then, Boston Scientific Corporation has lost 17.76% as of 07/27/2012's recent price of $5.00.
If you would have followed the previous Northland Securities's recommendation on BSX, you would have lost 17.76% of your investment in 147 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/27/2012 8:25 AM Hold
5.00 5.50
as of 12/31/2012
1 Week   
1 Month   
3 Months   
1 YTD down  -17.76 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/2/2012 8:25 AM Buy
6.08 7.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy